Osaic Holdings’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85K | Sell |
|
|||||
|
2025
Q1 | $7.24K | Sell |
|
|||||
|
2024
Q4 | $12.3K | Buy |
|
|||||
|
2024
Q3 | $3.15K | Hold |
|
|||||
|
2024
Q2 | $2.85K | Sell |
|
|||||
|
2024
Q1 | $4.59K | Buy |
|
|||||
|
2023
Q4 | $2.02K | Sell |
|
|||||
|
2023
Q3 | $39.8K | Buy |
|
|||||
|
2023
Q2 | $45K | Sell |
|
|||||
|
2023
Q1 | $45.4K | Sell |
|
|||||
|
2022
Q4 | $52.6K | Buy |
|
|||||
|
2022
Q3 | $7K | Hold |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $50K | Buy |
|
|||||
|
2021
Q4 | $35K | Sell |
|
|||||
|
2021
Q3 | $50K | Sell |
|
|||||
|
2021
Q2 | $53K | Buy |
|
|||||
|
2021
Q1 | $50K | Buy |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $34K | Sell |
|
|||||
|
2020
Q2 | $40K | Buy |
|
|||||
|
2020
Q1 | $28K | Buy |
|